ARCHIVES

Screening Guidelines Differ Among Major Medical Organizations

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations

April 19, 1974

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987